HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy

Fletcher, JA; Debiec-Rychter, Maria; Swank, S; Morgan, J; Liegl, B; Rege, TA; Heinrich, MC; Corless, CL; Donsky, R; Fletcher, CDM; Raut, CP; Marino-Enriquez, A; Blackman, RK; Proja, D; Sang, J; Smith, D; Foley, KP; Ou, W; Wang, Y; Demetri, GD

doi:10.1158/1535-7163.TARG-09-B184

Proceedings

HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy

Author:

Fletcher, JA

Debiec-Rychter, Maria ; Swank, S ; Morgan, J ; Liegl, B ; Rege, TA ; Heinrich, MC ; Corless, CL ; Donsky, R ; Fletcher, CDM ; Raut, CP ; Marino-Enriquez, A ; Blackman, RK ; Proja, D ; Sang, J ; Smith, D ; Foley, KP ; Ou, W ; Wang, Y ; Demetri, GD

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, 1112 Oncology and Carcinogenesis, 1115 Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis, 3101 Biochemistry and cell biology, 3211 Oncology and carcinogenesis

Proceedings HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy

Author:

Keywords:

Proceedings

HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy